Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 6Spondylitis, Ankylosing 2Psoriasis 2Crohn Disease 2Colitis, Ulcerative 2Uveal Melanoma 1Plaque Psoriasis 1Melanoma 1Hidradenitis Suppurativa 1Healthy Adult Male 1Healthy 1Acne Vulgaris 1Abscess 1

Interventions

Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Healthy Adult Male × Adalimumab × Clear all
NCT07181694 2025-10-03

A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects

Biocad

Phase 1 Recruiting
444 enrolled

Healthy Adult Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡